Immunofluorescence characterization of light chains in human nephropathies
- PMID: 3129870
- DOI: 10.1007/BF00844295
Immunofluorescence characterization of light chains in human nephropathies
Abstract
Renal tissue from 185 patients with various nephropathies were studied by immunofluorescence, in order to look for the frequency and potential predominance of kappa or lambda light chain glomerular deposits. Four normal renal biopsies were used as controls. An overall study shows that light chains were present in glomeruli in 136 out of 185 cases; kappa light chain deposits were more frequent than lambda light chain deposits (73.5% and 64.3% respectively). An analytical study shows that this was not observed in all nephropathies studied. In mesangial IgA nephropathy, lambda light chain deposits were seen in 81% of cases (29 out of 37) and kappa light chain deposits were observed in 78% (30 out of 37 cases). In lupus nephritis, lambda light chain deposits were present in 13 out of 14 cases (92.8%) whereas kappa light chain deposits were demonstrated in 12 cases (85.7%). In other nephropathies such as membranous, endocapillary proliferative and amyloid nephritis, kappa was the predominant light chain observed in glomeruli or was present in the same number of cases as lambda light chain (mesangiocapillary glomerulonephritis). These findings show that in certain nephritides, for example IgA nephropathy and lupus nephritis, IgA and IgG deposits are mainly composed of lambda light chain in contrast with the normal kappa: lambda ratio in human serum of 2:1.
Similar articles
-
The immunochemical characterization of the light chains in the mesangial IgA deposits in IgA nephropathy.Am J Clin Pathol. 1986 May;85(5):548-51. doi: 10.1093/ajcp/85.5.548. Am J Clin Pathol. 1986. PMID: 3085470
-
Light chain composition of IgA in IgA nephropathy.Am J Kidney Dis. 1988 May;11(5):425-9. doi: 10.1016/s0272-6386(88)80056-8. Am J Kidney Dis. 1988. PMID: 3130751
-
Predominant synthesis of IgA with lambda light chain in IgA nephropathy.Kidney Int. 1988 Feb;33(2):584-9. doi: 10.1038/ki.1988.37. Kidney Int. 1988. PMID: 3129610
-
Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.Nephrology (Carlton). 2016 Jul;21 Suppl 1:48-52. doi: 10.1111/nep.12775. Nephrology (Carlton). 2016. PMID: 26971743 Review.
-
IgG Subclass Staining in Routine Renal Biopsy Material.Am J Surg Pathol. 2016 May;40(5):617-26. doi: 10.1097/PAS.0000000000000605. Am J Surg Pathol. 2016. PMID: 26848798 Review.
Cited by
-
Removal of a C-terminal serine residue proximal to the inter-chain disulfide bond of a human IgG1 lambda light chain mediates enhanced antibody stability and antibody dependent cell-mediated cytotoxicity.MAbs. 2013 May-Jun;5(3):418-31. doi: 10.4161/mabs.24291. Epub 2013 Apr 8. MAbs. 2013. PMID: 23567210 Free PMC article.
-
Clinicopathological Spectrum of Diabetic and Non-diabetic Renal Lesions in Patients with Diabetes Mellitus: An Experience from A Tertiary Care Center.Iran J Pathol. 2024;19(3):311-317. doi: 10.30699/IJP.2024.2024462.3270. Epub 2024 Jul 24. Iran J Pathol. 2024. PMID: 39687457 Free PMC article.
-
Clinicopathologic and Prognostic Study of Primary IgA Nephropathy With Light Chain λ Restriction in the Mesangial Deposits.Kidney Int Rep. 2022 Jan 26;7(4):776-785. doi: 10.1016/j.ekir.2022.01.1053. eCollection 2022 Apr. Kidney Int Rep. 2022. PMID: 35497802 Free PMC article.
-
Clinicopathological significance of monoclonal IgA deposition in patients with IgA nephropathy.Clin Exp Nephrol. 2017 Apr;21(2):266-274. doi: 10.1007/s10157-016-1275-7. Epub 2016 May 12. Clin Exp Nephrol. 2017. PMID: 27170372
-
Clinicopathologic Significance of Predominant Lambda Light Chain Deposition in IgA Nephropathy.Kidney Int Rep. 2022 Aug 17;7(11):2462-2473. doi: 10.1016/j.ekir.2022.08.003. eCollection 2022 Nov. Kidney Int Rep. 2022. PMID: 36531879 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Miscellaneous